throbber
AMERICAN
`ASSOCIATION FO R THE
`ADVANCEMENT O F
`SCIENCE
`
`e
`
`CIENCE
`
`PROPERTY OF
`KK SHERWOOD LIBRARY
`HARBORVIEW MEDK:AL CENTER
`DO NOT REMOVE
`
`15 AUGUST 1986
`VoL. 233 • PAGEs 693-816
`
`$2.50
`
`BIOEPIS EX. 1059
`Page 1
`
`

`

`AMERICAN
`ASSOCIATION FOR THE
`ADVANCEMENT OF
`SCIENCE
`
`SciENCE ISSN 0036-8o7s
`
`15 AUGUST 1936
`VOLUME 233
`NUMBER4765
`
`699
`
`MIIHIUQm- 701
`Mk§@ill§lhif- 702
`MRDII4i@IJ41111- 704
`Letters
`
`707
`
`Resean·h Artides
`
`Rep<H'b
`
`712
`
`713
`715
`717
`
`720
`
`722
`
`723
`
`727
`
`734
`
`740
`
`747
`
`755
`
`758
`
`•
`
`•
`
`This Week in Science
`
`The United States and the IIASA Connection
`
`Structural Basis for Antigen-Antibody Recognition: R. HUBER
`
`A Novel Strain of Recklessness • Rifkin Against the World
`
`Nuclear Waste: D. F. UTTER; A.M. WEINBERG; P. T. VERNIER; R . A. PALMER;
`P. WILSON; K. ANDERSON
`
`U .S., Japan Reach Truce in Chips War
`
`Computers in Class at the Awkward Age
`
`The Chesapeake Bay's Difficult Comeback
`Briefing: Air Force to Mothball Vandenberg, Reduce Reliance on Shuttle •
`Research Fares Well in New French Budget • Saving the Whales Faces New
`Hazard-Research Whaling • NY Bar Calls for Overhaul of R&D Enterprise •
`Graham Nomination Still in Limbo
`
`New Fossil Upsets Human Family
`
`Mathematicians Recognize Major Discoveries
`
`Depression Research Advances, Treatment Lags • Manic Depression and
`Creativity
`
`Metals and DNA: Molecular Left-Handed Complements: J_ K. BARTON
`
`Conservation in South America: Problems, Consequences, and Solutions:
`M . A. MAREs
`
`Cell Recognition by Neuronal Growth Cones in a Simple Vertebrate Embryo:
`J. Y. KUWADA
`Three-Dimensional Structure of an Antigen-Antibody Complex at 2.8 A
`Resolution: A. G. AMrr, R. A. MARIUZZA, S. E. V . PHILLIPS, R. J. POLJAK
`
`The Predicted Structure of Immunoglobulin Dl.3 and Its Comparison with the
`Crystal Structure: C. CHOTHIA, A. M . LESK, M. LEVITT, A. G. AMrr,
`R . A. MAR!UZZA, S. E. V. PHILLIPS, R. J. POLJAK
`
`Cambrian River Terraces and Ridgetops in Central Australia: Oldest Persisting
`Landforms? : A. J. STEWART, D. H . BLAKE, C. D. OLLIER
`
`SCIENCE Ia published weekly on Friday, except the laat week In December, and with a plua luue In * Y,!!!:
`American Auoclatlon for the Advancement of Science, 1333 H Street, NW, Wuhlngton, DC 20005. 5eCO
`postage (publication No. 484460) pa;q at Washington, DC, and at an add~ional entry. Now combined w~ The~
`Monthly® Copyright Cl 1986 by the American Association for the Advancement of Science. The title SCIENCE~
`istered trademark of the AAAS. Domestic individual membership and subscription (51 issues) : $65. Domestic in
`subscription (51 issues) : $98. Foreign postage extra: Canada $24, other (surface mail) $27, air-surface via Amster:"
`$65. First class, airmail, school-year, and student rates on request. Single copies $2.50 ($3 by mail); back 1ssu~
`($4.50 by mail); Biotechnology issue, $5.50 ($6 by mail) ; classroom rates on request; Guide to Biotechnology ~
`and Instruments $16 ($17 by mall). Change of addi'HB: allow 6 weeks, giving old and new addresses and se
`aocount number. Authorization to photocopy material for internal or personal use under circumstances not falh~
`piG'
`the fair use provisions of the Copyright Acl is granted by AAAS to libraries and other users registered w~ the
`Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $1 per copy plus ~.tO. pet ()03&(cid:173)
`is paid direclly to CCC, 21 Congress Street, Selem, Massachusetts 01970. The identification code for Scl8~ 15
`la ln-
`8075/83$1 + .10. Postmaster: Send Form 3579 to Science, 1333 H Street, NW, Washington, DC 20005. SciBfiCB
`objectt
`dexed in the Reader's Guide to Periodical Literature and in several specialized Indexes.
`The American Association for the Advancement of Science was founded in 1848 and incorporated in 1874. ~--lhiiiV
`are to further the work of scientists, to facilitate cooperation among them, to foster scientific freedom and respuo';djjp.
`to improve the enecriveness of science in the promotion of human we~are, and to increase public understanding
`preciation of the Importance and promise of the methods of science in human progress.
`
`SCIENCE, VOL.
`
`BIOEPIS EX. 1059
`Page 2
`
`

`

`SciENCE
`
`(Upper) Three-dimensional structure of an antigen-antibody complex.
`COVER
`The antigen is Iyzozyme (green, with a protruding residue, glutamine-121 in red).
`(Lower) The antigen and the antibody have been pulled apart to reveal their
`complementary contacting surfaces. See pages 747 and 755. [A. G. Amit et al.,
`Institut Pasteur, Paris, France]
`
`761
`
`Equatorial Pacific Seismic Reflectors as Indicators of Global Oceanographic
`Events: L. A. MAYER, T. H . SHIPLEY, E. L. WINTERER
`
`765
`
`Two Magnetoreception Pathways in a Migratory Salamander: ]. B. PHILLIPS
`
`767 Molecular Cloning of the Chicken Progesterone Receptor: 0 . M. CoNNEELY,
`W. P. SULLIVAN, D . 0 . ToFT, M. BIRNBAUMER, R. G. CooK, B. L. MAxwELL,
`T. ZARUCKI-SCHULZ, G. L. GREENE, w. T. SCHRADER, B. w. O'MALLEY
`770 Distinct Pathways of Viral Spread in the Host Determined by Reovirus S1 Gene
`Segment: K. L. TYLER, D . A. McPHEE, B. N. FIELDS
`
`774
`
`776
`
`Psychotornimesis Mediated by K Opiate Receptors: A. PFEIFFER, V. BRANTL,
`A. HERZ, H . M. EMRICH
`
`Transplantation of Fetal Hematopoietic Stem Cells in Utero: The Creation of
`Hematopoietic Chimeras: A. W. FLAKE, M. R. HARRISON, N . S. ADziCK,
`E. D. ZANJANI
`
`778 Amplification of an Esterase Gene Is Responsible for Insecticide Resistance in a
`California Culex Mosquito: C. MoucHES, N . PASTEUR,]. B. BERGE,
`0 . HYRIEN, M. RAYMOND, B. RoBERT DE SAINT VINCENT et al.
`
`780 Occult Drosophila Calcium Channels and Twinning of Calcium and
`Voltage-Activated Potassium Channels: A. WEI and L. SALKOFF
`
`783 A Protein Induced During Nerve Growth (GAP-43) Is a Major Component of
`Growth-Cone Membranes: ] . H . P. SKENE, R . D. ]ACOBSON, G. ]. SNIPES,
`C. B. McGUIRE,]. ]. NORDEN,]. A. FREEMAN
`Chromosome Y -Specific DNA Is Transferred to the Short Arm of X
`Chromosome in Human XX Males: M. ANDERSSON, D . C. PAGE,
`A. DE LA CHAPELLE
`
`786
`
`788 Active Human-Yeast Chimeric Phosphoglycerate Kinases Engineered by Domain
`Interchange: M. T. MAs, C. Y. CHEN, R. A. HITZEMAN, A. D . RIGGS
`
`793 Annual Meeting: Call for Contributed Papers
`
`794 A Cycle of Outrage, reviewed by H . Molotch • Les Fourrnis et les Plantes,
`R. C. BucKLEY • Geology of Sedimentary Phosphates, V. E. McKELVEY •
`Some Other Books of Interest • Books Received
`
`797 Benchtop Gas Chromatograph Mass Spectrometer • Mathematics Software for
`Personal Computer • Electrophoresis Blotting Apparatus • Bibliographic
`Software • Peptide Synthesizer • Programmable Viscometer • Database for
`Chemists • Literature
`
`Robert McC. Adams
`Robert W. Berliner
`Floyd E. Bloom
`Mary E. Clutter
`Mildred S. Dresselhaus
`Donald N. Langenberg
`Dorothy Nelkin
`Unda S. Wilson
`William T. Golden
`Treasurer
`William D. Carey
`Executive Officer
`
`Edttort.l Board
`David Baltimore
`William F. Brinkman
`Ansley J. Coale
`Joseph L. Goldstein
`James D. Idol, Jr.
`Leon Knopoft
`Seymour Upset
`WaMer Massey
`Oliver E. Neison
`Allen Newell
`Ruth Patrick
`David V. Ragone
`Vera C. Rubin
`Howard E. Simmons
`Solomon H. Snyder
`Robert M. Solow
`
`Board of Reviewing
`Edttora
`Qais AI-Awqati
`James P. Allison
`Luis W. Alvarez
`Don L. Anderson
`C. Paul Bianchi
`Elizabeth H. Blackburn
`Floyd E. Bloom
`Char1es A. Cantor
`James H. Clark
`Biuce F. Eldridge
`Stanley Falkow
`Theodore H. Geballe
`Roger I. M. Glass
`
`Stephen P. Goft
`Robert B. Goldberg
`Patricia S. Goldman-Rakic
`Corey S. Goodman
`Richard M. Held
`Gloria Heppner
`Eric F. Johnson
`Konrad B. Krauskopf
`Kar1 L. Magleby
`Joseph B. Martin
`John C. McGift
`Mon Meister
`Mortimer Mishkin
`Peter Otson
`Gordon H. Orians
`John S. Pearse
`Yeshayau Pocker
`Jean Paul Revel
`
`Frederic M. Richards
`James E. Rothman
`Thomas C. Schelling
`Ronald H. Schwartz
`Stephen M. Schwartz
`Otto T. Solbrig
`Robert T. N. Tjian
`Virginia Trimble
`Geerat J. Vermeij
`Martin G. Weigert
`Irving L. Weissman
`George M. Wh~esides
`Owen N. Witte
`William B. Wood
`Harriet Zuckerman
`
`TABLE OF CONTENTS 697
`
`BIOEPIS EX. 1059
`Page 3
`
`

`

`Three-Dimensional Structureoof an ¥tigen(cid:173)
`) Antibody Complex at 2.8 A Resolution
`A. G. AMIT, R. A. MA.ruuzzA, S. E. V. PHILLIPS, R. J. PoLJAK
`
`The 2.8 A resolution three-dimensional structure of a
`complex between an antigen (lysozyme) and the Fab
`fragment from a monoclonal antibody against lysozyme
`has been determined and refined by x-ray crystallographic
`techniques. No conformational changes can be observed
`in the tertiary structure of lysozyme compared with that
`determined in native crystalline forms. The quaternary
`structure ofFab is that of an extended conformation. The
`antibody combining site is a rather flat surface with
`protuberances and depressions formed by its amino acid
`side chains. The antigen-antibody interface is tighdy
`packed, with 16 lysozyme and 17 antibody residues
`making close contacts. The antigen contacting residues
`belong to two stretches of the lysozyme polypeptide
`chain: residues 18 to 27 and 116 to 129. All the comple(cid:173)
`mentarity-determining regions and two residues outside
`hypervariable positions of the antibody make contact with
`the antigen. Most of these contacts ( 10 residues out of 17)
`are made by the heavy chain, and in particular by its third
`complementarity-determining region. Antigen variability
`and antibody specificity and affinity are discussed on the
`basis of the determined structure.
`
`T HE BINDING OF FOREIGN ANTIGENS TO COMPLEMENTARY
`
`structures on the surface of B and T lymphocytes represents
`the initial step in the sequence of events leading to activation
`of the immune system. The receptor molecule on the surface of B
`lymphocytes responsible for antigen recognition is membrane
`immunoglobulin. A mature B cell produces and inserts into its
`plasma membrane only limited amounts of a single kind of immuno(cid:173)
`globulin. Contact with antigen results in the expansion of B cell
`clones specific for that antigen and in their differentiation into
`plasma cells capable of producing and secreting large amounts of
`antibody of the same specificity (monoclonal antibody) .
`Antibody molecules of the immunoglobulin G (IgG) class, the
`most abundant in normal serum, are composed of two identical light
`(L) and two identical heavy (H ) polypeptide chains. The amino
`terminal regions of the H and L chains, termed V H and V L, are each
`about 110 amino acids long and have variable (and homologous)
`amino acid sequences. The constant (C) half of the L chain, CL, and
`the constant regions CH 1, CH2, and CH3 of the H chain, each about
`100 amino acids long, have homologous sequences that belong to
`one of a few classes (K and A for L chains; JJ.., B, -y, e, and a for H
`chains). The V H and V L regions each contain three hypervariable or
`complementarity-determining regions (CDR1, CDR2, and CDR3)
`responsible for antigen recognition. These are flanked by less
`variable (FR1, FR2, FR3, and FR4) "framework" regions (1) .
`Present understanding of the three-dimensional structure of
`
`antibody combining sites is based on x-ray diffraction studies of
`myeloma immunoglobulins as reviewed (2). These have shown that
`the conformation of combining sites is determined by the amino
`acid sequences, unique to each different antibody, of the CDR's.
`The structures of two complexes of antigen-binding fragments
`(Fab) of myeloma immunoglobulins with small ligands have also
`been determined (3, 4). Although these studies resulted in useful
`models for ligand-antibody interactions, they are insufficient to
`establish unequivocally the precise size and shape of antibody
`combining sites, the nature and extent of antigen-antibody interac(cid:173)
`tions, and the occurrence of possible conformational changes (if
`any) in the antibody after antigen binding. In addition, the precise
`structure of antigenic determinants on protein molecules remains to
`be determined (5) . Equally important are questions concerning the
`nature of possible conformational changes in the complexed antigen
`and the effect of single amino acid substitutions on antigenic
`specificity and antigen recognition by the antibody.
`We have recently determined the three-dimensional structure of
`an antigen-antibody complex, one between lysozyme and the Fab
`fragment of a monoclonal antibody to hen egg white lysozyme, at 6
`A resolution (6). We have since extended the resolution of the x-ray
`structure determination to 2.8 A, and now present a complete
`description of antigen-antibody interactions in the complex.
`Structure determination. The production of hybrid cell lines
`secreting murine monoclonal antibody to hen egg white lysozyme,
`and the purification, crystallization (7), and 6 A resolution crystal
`structure determination ( 6) of the complex between Fab D 1.3 and
`lysozyme have been described. Crystals grown from solutions
`containing 15 to 20 percent polyethylene glycol 8000 at pH 6.0 are
`monoclinic, space group P2~, with a= 55 .6, b = 143.4, c = 49.1
`A, 13 = 120.5°, and one molecule of complex per asymmetric unit.
`Three heavy atom isomorphous derivatives were prepared with
`(NH4)2PtC4, K3F5U02, and p-hydroxymercuribenzenesulfonate.
`X-ray intensities were measured to 2.8 A resolution with the use of a
`four-circle automatic diffractometer. Heavy atom sites were refined
`in alternate cycles of phasing and refinement (8); isomorphous
`phases, including anomalous scattering contributions (9), were
`calculated. The mean figure of merit (10) to 2.8 A resolution was
`0.47 for 15592 reflections. The electron density map calculated
`from these data was not readily interpretable, presumably because of
`lack of isomorphism of the heavy atom derivatives affecting phase
`determination at high resolution. The phases were further refined by
`a density modification technique (11) with a molecular envelope
`traced from the Fab-lysozyme model determined at 6 A resolution
`(6). The resulting phases depend only on the observed data and the
`overall shape and position of the complex, but are independent of
`the detailed conformation of the previous model ( 6). The resulting
`
`A. G. Amit, R. A. Mariuzza, and R. ]. Poljak are in the Departemenr d'Immunologie,
`Instirut Pasteur, 75724 Paris Cedex 15, France. S. E. V. Phillips is in the Astbury
`Department of Biophysics, Universiry of Leeds, Leeds, United Kingdom.
`
`15 AUGUST 1986
`
`RESEARC H ARTICLES 74 7
`
`BIOEPIS EX. 1059
`Page 4
`
`

`

`Fig. l. Stereo diagram of the Ca skeleton of the
`complex. Fab is shown (upper right) with the heavy
`and light chains with thick and thin bonds, respec(cid:173)
`tively. The lysozyme active site is the cleft containing·
`the label HEL. Antibody-antigen interactions are
`most numerous between lysozyme and the heavy
`chain CDR loops.
`
`CHI
`
`CHl
`
`electron density map was much improved, and an atomic model was
`fitted to it on an Evans and Sutherland PS300 interactive graphics
`system with the use of the program FRODO (12). The amino acid
`sequence ofFab Dl.3 was derived from the corresponding light and
`heavy chain complementary DNA (eDNA) sequences (13). Of the
`562 amino acid residues in the complex, 24 of those in the constant
`regions could not be located in the initial map. The atomic
`coordinates were submitted to alternate cycles of restrained crystal(cid:173)
`lographic least-squares refinement (14) and model building. The
`model was checked in the later stages of refinement by sequentially
`omitting segments of the polypeptide chain (up to 20 percent of the
`total) and rebuilding them in maps phased from the remainder of
`the structure in combination with isomorphous replacement data
`(15) . All residues have now been located, and the current crystallo(cid:173)
`graphic R factor is 0.28 for all data in the 20 to 2.8 A resolution
`range. (R = :£ I IFoi-IFcl I I :£1Fol, where Fo, Fe are the observed
`and calculated structure factors of x-ray reflections_) No attempt was
`made to locate solvent molecules. Two isotropic temperature factors
`were used for each residue, one for the main chain atoms, and
`another for the side chain atoms. Stereochemical restraints were
`adjusted to give a standard deviation in c-c bonds of ±0.03 A. No
`restraints were applied between residues across the antibody-antigen
`interface. Atomic coordinates will be deposited at Brookhaven Protein
`Data Bank after higher resolution and crystallographic refinement.
`Conformation of the complexed antigen and of the Fab. The
`overall structure of the complex at 2.8 A resolution (Fig. 1) confirms
`the results of the 6 A resolution study (6). The assignment of the H
`and L polypeptide chains of Fab is unchanged. The closely packed 13
`sheets are seen in Fab as are the helical and p-sheet structures
`surrounding the active site in lysozyme. The Fab appears in an
`almost fully extended conformation, with a definite" separation
`between the variable (V) and constant (C) domains. With the
`exception of this difference in quaternary structure, Fab Dl.3
`compares closely to other known Fab's (4, 16), except in the CDR
`loops. Predicted structures for D 1.3 (17) based on other Fab's also
`agree well with the determined structure in the framework 13-sheet
`regions and in some, but not all, of the CDR loops. The relative
`disposition of the variable subunits of the H chain (V H) and of the L
`chain (V L), is unaltered, indicating no change in quaternary struc(cid:173)
`ture in the V domain resulting from antigen binding. Since the
`crystal structure of the unliganded Fab Dl.3 has not been deter(cid:173)
`mined, detailed changes in antibody conformation remain to be
`verified. However, the similarity with other Fab structures suggests
`
`that possible conformational changes would be small. This observa(cid:173)
`tion is in agreement with that made by nuclear magnetic resonance
`(NMR) on the unliganded and hapten-liganded (dinitrophenol)
`mouse myeloma protein MOPC315 (18) .
`A least-squares fit of Co: atoms of lysozyme in the complex and
`native lysozyme refined at 1.6 A in its tetragonal crystal form (19 ) gives
`a root-mean-square (rms) deviation of 0.64 A between the two (see
`Fig. 2). Since the error in atomic positions in the complex can
`be estimated (20) to be approximately 0.6 A, the difference is not
`significant. Furthermore, the largest changes (up to 1.6 A) occur in
`regio.ns remote from antibody contacts. Similar comparisons of
`native tetragonal lysozyme with other crystal forms gave rms
`deviations of 0.88 A with triclinic lysozyme refined from x-ray and
`neutron diffraction data (21) and 0.46 A for orthorhombic lysozyme
`determined at physiological temperature (22). Some differences in
`side chain conformation are observed between tetragonal and
`complexed lysozyme, but close examination with computer graphics
`revealed these to be similar to differences observed between different
`crystal structures of native lysozyme. Thus, complex formation with
`antibody Dl.3 produces no more distortion of the structure of
`lysozyme than does crystallization.
`The antigen-antibody interface. The interface between antigen
`and antibody extends over a large area with maximum dimensions of
`about 30 by 20 A (Figs. 3 and 4). The antibody combining site
`appears as an irregular, rather flat surface with protuberances and
`depressions formed by the amino acid side chains of the CDR's of
`V H and V L· In addition, there is a small cleft between the third
`CDR's ofVH and VL, corresponding to the binding site character(cid:173)
`ized in hapten-antibody complexes (3, 4 ). The cleft accepts the side
`chain Gin 121 of lysozyme although this is not the center of the
`antigen-antibody interface (Fig. 3).
`The lysozyme antigenic determinants recognized by Dl.3 are
`made up of two stretches of polypeptide chain, comprising residues
`18 to 27 and 116 to 129, distant in the amino acid sequence but
`adjacent on the protein surface. All six CDR's interact with the
`antigen and in all, 16 antigen residues make close contacts with 17
`antibody residues (Tables 1 and 2). Two antibody contacting
`residues, V L Tyr 49 and V H Thr 30, are just outside segments
`commonly defined as CDR's [sequence numbers are as in Kabat et
`a/.. (1) except for VH CDR3; see Tables 2 and 3]. VH Thr 30 is a
`constant or nearly constant residue in mouse H chain subgroups I
`and II, as is V L Tyr 49 in mouse kappa chains. While the interaction
`of V L Tyr 49 with antigen is relatively weak (one van der Waals
`
`SCIENCE, VOL. 233
`
`BIOEPIS EX. 1059
`Page 5
`
`

`

`Fig. 2. TheCa skeleton of lysozyme in the complex
`(thick trace) superimposed by least squares on that of
`native lysosyrne in the tetragonal crystal form (thin
`trace). The interface to Fab is at the top, and no
`significant conformation change is apparent in this
`region. Greater differences, although still not signifi(cid:173)
`cant at this resolution, occur at the bottom of the

`molecule.
`
`described above, a tightly packed interface which mostly excludes
`solvent.
`.
`Although the antigen-antibody interface involves all six CDR's of
`the Fab, there are more interactions with VH than with VL CDR's,
`and with VH CDR3 in particular (Tables 1 to 3). The geometrical
`
`:2
`5
`0
`
`"' lf
`ty
`0
`
`VI
`e
`n
`11!
`
`I~
`).
`JJ
`·e
`3
`11
`
`contact between its aromatic side chain and Cct of Gly 22 of
`lysozyme), there is a strong hydrogen bond between the hydroxyl
`group of VH Thr 30 and the carbonyl oxygen of Lys 116 of
`lysozyme. This specific interaction involving an invariant antibody
`residue demonstrates
`that the functional distinction between
`"framework" (FR) and CDR residues, although largely maintained,
`is not absolute. The interacting surfaces are complementary, with
`protruding side chains of one lying in depressions of the other (Fig.
`3) in common with other known protein-protein interactions (23) .
`There are many van der Waals interactions interspersed with
`hydrogen bonds. This is most striking for the side chain of Gin 121,
`which penetrates deeply into the Fab, surrounded by three aromatic
`side chains, V L T yr 32 and Trp 92 and V H T yr 101 (Figs. 3, 4, and
`5). Its amide nitrogen forms a strong, buried hydrogen bond to the
`main chain carbonyl oxygen ofV L Phe 91 (Fig. 5 and Table 3). The
`adjacent V H Tyr 101 extends to the surface of lysozyme, its terminal
`hydroxyl group forming hydrogen bonds to the main chain nitro(cid:173)
`gens of Val120 and Gin 121 , and to Oo1 of Asp 119. Many
`hydrogen bonds occur between the side chains of the antigen and
`the main polypeptide chain of the antibody, and vice versa (Table
`3). Hydrogen bonds between main polypeptide chain atoms, similar
`to those in f3-sheet structures, occur between Lys 116 of lysozyme
`and VH Gly 31 , and between Gly 11 7 and VH Gly 53, where the
`lack of side chains allo ws close approach. There are many side chain(cid:173)
`side chain close interactions forming, together with the ones
`
`Fig. 3. Space filling representation of Fab Dl.3 and lysozyme. (A) Antigen(cid:173)
`antibody complex structure as determined in this work. The antibody H
`chain is shown in blue, the L chain in yellow, lysozyme in green, and
`Gin 121 in red. (B) The Fab and lysozyme models have been pulled apart to
`indicate protuberances and depressions of each fit in complementary surface
`features of the other. Compare with (A) above. At the top of the interface,
`protruding V L residues His 30 and Tyr 32 fit into a depression in lysozyme,
`between residues Ilc 124 and Leu 129 (see also Table 1 ). Below the Gin 121,
`!n red, a protuberance of lysozyme consisting of residues around Thr 118 fits
`uuo a surface depression fo rmed by V H residues of CDR1 and CDR2 (V H
`Trp 52 can be seen at the bottom of this depression). (C) End-on views of
`the antibody combining site (left) and the antigenic markers of lysozyme
`recognized by antibody Dl.3, formed from (B) above, by rotating each of
`the molecules approximately 90° about a vertical axis. Contacting residues on
`the antigen and antibody arc shown in red, except for Gin 121 shown in light
`purple. L chain residues that contact the antigen are labeled 1 (His 30), 2
`(Tyr 32), 3 (Tyr 49), 4 (Tyr 50), 5 (Phe 91 ), 6 (Trp 92), and 7 (Ser 93). H
`chain residues that contact the antigen are labeled 8 (Thr 30), 9 (Gly 31 ), 10
`(Tyr 32), 11 (Trp 52), 12 (Gly 53 ), 13 (Asp 54), 14 (Arg 99), 15 (Asp 100),
`16 (Tyr 101), and 17 (Arg 102); see Table l. Lysozyme residues thatcontact
`the antibody are labeled 1 (Asp 18), 2 (Asn 19), 3 (Arg 21 ), 4 (Gly 22), 5
`(Tyr 23), 6 (Ser 24), 7 (Leu 25), 8 (Asn 27), 9 (Lys 116), 10 (Gly 117), 11
`(Thr 118), 12 (Asp 119), 13 (Val 120), 14 (Gin 121), 15 (Ile 124), and 16
`(Leu 129). Gin 121 fits into the antibody surface pocket surrounded by V L
`and VH residues 2, 5, 6, 7, and 16 (Table 1).
`
`15 AUGUST 1986
`
`RESEARCH ARTICLES 749
`
`----------------~~~=-~------
`
`BIOEPIS EX. 1059
`Page 6
`
`

`

`Fig. 4. Stereo diagram of the antibody-antigen interface in
`a similar orientation to Fig. l. All atoms are shown for
`those residues involved in the interaction. Heavy and light
`main chains are indicated by thick and thin bonds, respec(cid:173)
`tively, and hydrogen bonds by dotted lines. Lysozyme
`residues broadly lie below the diagonal from top left to
`lower right of the diagram.
`
`center of the surface lies near V H CD R3, and is occupied by the side
`chain of V H Asp 100, which forms H bonds to the side chains of
`Ser 24 and Asn 27 of lysozyme. Of the antibody hypervariable
`regions, V L CDR2 contributes the least to antigen binding. A large
`number of antibody side chains in the interface (9 out of 15 if we
`exclude Gly residues) are aromatic, thus presenting large areas of
`hydrophobic surface to the antigen; in addition, some of them such
`as V L Tyr 50 and V H Tyr 101 participate in hydrogen bonding with
`the antigen via their polar atoms. In all, 748 A2 or about ll percent
`of the solvent-accessible surface (24) of lysozyme is buried on
`complex formation, together with 690 A2 for the antibody.
`Antigen variability and antibody specificity. The fine specificity
`of monoclonal antibody Dl.3 for other avian lysozymes shows its
`ability to distinguish a single amino acid change in the antigen, at
`position 121. Fab Dl.3 binds hen egg white lysozyme with an
`equilibrium affinity constant of :4.5 X l07M- 1 (25). Bobwhitt: quail
`lysozyme, with four amino acid sequence differences (26) from hen
`lysozyme but none in the interface with Fab Dl.3, binds with
`sinlilar affinity (25). The binding of antibody D 1.3 to the lysozymes
`of partridge [three amino acid differences (26)], California quail
`[four amino acid differences (26)], Japanese quail [six amino acid
`differences (27)], turkey [seven amino acid differences (28)], and
`pheasant and guinea fowl [ten an1ino acid differences each (29)] is
`undetectable (KA < 1 x l05M - 1
`) with the enzyme-linked inlmu(cid:173)
`noabsorption assay used in our laboratory. These lysozymes differ
`from hen lysozyme in the anlino acid residue at position 121, which
`makes close contacts with the antibody. Except for Japanese quail
`and pheasant lysozymes, all have Gln replaced by His.
`
`Table l. Antibody residues involved in contact with lysozyme. Sequence
`positions are numbered as in Kabat eta/. (1) except for V H CDR3, where the
`numbers of Kabat et a/ .. (1) arc given in parentheses.
`
`Antibody residues
`
`Lysozyme residues in contact
`
`Light chain
`CDR1
`
`FR2
`CDR2
`CDR3
`
`Heavy chain
`FR1
`CDR1
`
`CDR2
`
`CDR3
`
`750
`
`His 30
`Tyr 32
`Tyr49
`Tyr 50
`Phe 91
`Trp 92
`Ser 93
`
`Leu 129
`Leu 25, Gin 121, lie 124
`Gly22
`Asp 18, Asn 19, Leu 25
`Gin 121
`Gin 121, Ile 124
`Gin 121
`
`Thr 30
`Gly 31
`Tyr 32
`Trp 52
`Gly 53
`Asp 54
`Arg99 (96)
`Asp 100 (97)
`Tyr 101 (98)
`Arg 102 (99)
`
`Lys 116, Gly 117
`Lys 116, Gly 117
`Lys 116, Gly 11 7
`Gly 117, Thr ll8, Asp 119 .
`Gly 117
`Gly 117
`Arg 21, Gly 22, Tyr 23
`Gly 22, Tyr 23, Ser 24, Asn 27
`Thr ll8, Asp 119, Val120, Gin 121
`Asn 19, Gly 22
`
`A computer graphics analysis indicates that a His residue could be
`placed in the interface, in the space occupied by Gin 121, with small
`displacements of the contacting antibody side chains, maintaining
`the H bonds made by Gln 121. Conformational energy calculations
`(30) confirm this possibility, the total energy being little changed on
`substitution of His for Gln 121. The buried hydrogen bond is
`maintained with good geometry, and only very small shifts of neigh(cid:173)
`to accommodate
`the mutation.
`boring groups are necessary
`This seems to rule out steric hindrance in explaining the absence of
`complex formation when His occurs at position 121. Other possible
`explanations for the effect of this anlino acid substitution include the
`following. (i) His 121 could be charged, and consequently unstable
`in the hydrophobic pocket occupied by Gin 121; (ii) its side chain
`may have a different orientation from that of Gln, fornling, for
`example, a salt bridge with Asp 119; and (iii) substitution ofHis for
`Gln at position 121 may induce a local change of conformation in
`the polypeptide backbone making the antigenic determinant unrec(cid:173)
`ognizable by the antibody. Not enough information is available to
`decide on the relative importance of these factors. Nevertheless, the
`
`Table 2. Lysozyme residues in contact with antibody.
`
`Lysozyme
`residues
`
`Antibody residues
`in contact (No.)
`
`Lysozyme
`residues
`
`Antibody residues
`in contact (No.)
`
`Asp 18
`Asn 19
`Arg 21
`Gly22
`Tyr 23
`Scr 24
`Leu 25
`Asn 27
`
`1 L chain
`2H, L
`1H
`4 H(3), L
`2H
`1 H
`1 L
`1H
`
`Lys 116
`Gly 117
`Thr ll8
`Asp 119
`Val120
`Gin 121
`Ile 124
`Leu 129
`
`3H
`6H
`2H
`2H
`1H
`5 H (1), L(4)
`2L
`1L
`
`Table 3. Hydrogen bonded interactions between antibody and lysozyme.
`Sequence positions are numbered as in Kabat et a/. ( 1) except for V H CD R3
`where the numbers of Kabat eta/. (1) are given in parentheses.
`
`Antibody residue
`
`Lysozyme residue
`
`Light chain
`
`Heavy chain
`
`Ne2 His 30
`OTJ Tyr 50
`0
`Phe 91
`
`Oy1 Thr30
`N
`Gly 31
`N
`Gly 53
`NTJ1 Arg 99 (96)
`0&1 Asp 100 (97)
`0&2 Asp 100 (97)
`0T] Tyr 101 (98)
`OTJ Tyr 101 (98)
`OT] Tyr 101 (98)
`
`• Denotes the closest interactions (distances s 2.5 A).
`
`Leu 129
`0
`0&1 Asp 18
`Ne2 Gln 121*
`
`Lys 116*
`0
`Lys 116
`0
`Gly 117*
`0
`Gly 22
`0
`N&2 Asn 27
`0-y Ser 24 *
`Val120
`N
`Gln 121
`N
`0&1 Asp 119
`
`SCIENCE, VOL. Z33
`
`BIOEPIS EX. 1059
`Page 7
`
`

`

`Fig. 5. Stereo view of the environment of Gin 121
`with (above) atoms drawn with their van der Waals
`radii, showing the close packing of the three antibody
`aromatic rings around the antigen side chain. The
`dotted line indicates the hydrogen bond from Ne2 of
`Gin to the main chain carbonyl oxygen of V L Phe 9 L
`
`CDRIL
`
`fact that the His residue is not induced to fit into the interface
`position occupied by Gln 121 is in agreement with a "lock and key''
`model (see below) of complex formation between conformationally
`stable antigen and antibody structures.
`Japanese quail lysozyme has an Asn at position 121 and the
`additional differences Asn 19 ~ Lys and Arg 21 ~ Gln in the
`antigen-antibody interface. Asn 121 would be unable to form
`hydrogen bonds as strong as those of Gln 121. In addition,
`replacement of Asn 19 by Lys causes the loss of weak interactions
`between Ool of Asn 19 and N of VH Arg 102. The positively
`charged Lys 19 side chain would be repelled by VH Arg 102 and
`would probably remain outside the interface, further reducing
`packing efficiency. Only main chain atoms of Arg 21 make contact
`with Fab and the side chain is external; therefore changes at this
`position in the antigen surface are probably not detrimental to
`complex formation.
`The equilibrium affinity constant of Fab DL3 binding of hen
`lysozyme is 4.5 x 107M - 1
`• Other monoclonal antibodies to lyso(cid:173)
`zyme that we (25) and others (31) have obtained and characterized
`show similar affinity constants for the homologous lysozyme anti(cid:173)
`gen. Moreover, the determined equilibrium constants of protein
`antigens with their specific antibodies range from I05M - 1 to
`l0 10M - 1 (32). Thus, DL3 is a typical antibody of the monoclonal
`response in BALB/c mice and one of an about average affinity
`constant in immune responses to protein antigens in general.
`Comparison of evolutionarily related proteins has been used to
`identifY antigenic sites in proteins such as lysozyme (5, 25, 33). The
`detection of antigenic determinants by these fine specificity studies
`is biased toward the recognition of evolutionarily variable residues,
`such as Gln 121 by antibody DL3. As our r

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket